Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study

Abstract Background Eosinophilia is a significant factor in asthma severity; however, the prevalence of severe eosinophilic asthma in Saudi Arabia is largely unknown. We aimed to determine the prevalence of the eosinophilic (defined in this study as ≥ 300 cells/mm3 in blood), atopic (atopic phenotyp...

Full description

Bibliographic Details
Main Authors: Hamdan Al-Jahdali, Siraj Wali, Amr S. Albanna, Riyad Allehebi, Hussein Al-Matar, Mohamed Fattouh, Maarten Beekman
Format: Article
Language:English
Published: BMC 2022-02-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-022-01856-9
_version_ 1819281060476747776
author Hamdan Al-Jahdali
Siraj Wali
Amr S. Albanna
Riyad Allehebi
Hussein Al-Matar
Mohamed Fattouh
Maarten Beekman
author_facet Hamdan Al-Jahdali
Siraj Wali
Amr S. Albanna
Riyad Allehebi
Hussein Al-Matar
Mohamed Fattouh
Maarten Beekman
author_sort Hamdan Al-Jahdali
collection DOAJ
description Abstract Background Eosinophilia is a significant factor in asthma severity; however, the prevalence of severe eosinophilic asthma in Saudi Arabia is largely unknown. We aimed to determine the prevalence of the eosinophilic (defined in this study as ≥ 300 cells/mm3 in blood), atopic (atopic phenotype 1, defined in this study as > 100 IU/mL total serum IgE; atopic phenotype 2, defined in this study as > 150 IU/mL), and overlap phenotypes among patients with severe asthma in Saudi Arabia. Methods A cross-sectional study was conducted in centers specialized in severe asthma management. Patients aged ≥ 12 years with severe asthma were enrolled. Study patients responded to the Global Initiative for Asthma 2018 assessment of asthma control questionnaire and provided study investigators with current information related to the study objectives. Additional medical record data and a blood sample for total serum IgE and complete blood count were collected. Results A total of 101 patients were enrolled; 83% were female and the mean (standard deviation) age was 48.7 (13.2) years. Forty-five (45%) patients had the eosinophilic phenotype, 50 (50%) had atopic phenotype 1, and 25 (25%) had phenotypic overlap (eosinophilic and atopic 1). Forty-one (41%) patients had atopic phenotype 2 and 23 (23%) had phenotypic overlap (eosinophilic and atopic 2). Asthma control and oral corticosteroid use patterns were similar and there were no significant differences in number of asthma exacerbations across phenotypes. Conclusions In Saudi Arabia, 45% of patients with severe asthma had the eosinophilic phenotype, which is most likely an underestimation as no clinical features of eosinophilia were taken into account in the definition of eosinophilia. Approximately half of them had phenotypic overlap with the atopic phenotype. Trial registration NCT03931954; ClinicalTrials.gov, April 30, 2019.
first_indexed 2024-12-24T00:53:41Z
format Article
id doaj.art-aec2761443a347c2941be0d25936aa91
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-12-24T00:53:41Z
publishDate 2022-02-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-aec2761443a347c2941be0d25936aa912022-12-21T17:23:32ZengBMCBMC Pulmonary Medicine1471-24662022-02-0122111110.1186/s12890-022-01856-9Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional studyHamdan Al-Jahdali0Siraj Wali1Amr S. Albanna2Riyad Allehebi3Hussein Al-Matar4Mohamed Fattouh5Maarten Beekman6Department of Medicine - Pulmonary Division, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health SciencesDepartment of Medicine - Pulmonary Division, College of Medicine, King Abdulaziz UniversityDepartment of Medicine - Pulmonary Division, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health SciencesDepartment of Medicine - Pulmonary Division, King Fahad Medical CityDepartment of Medicine, Imam Abdulrahman Al Faisal HospitalAstraZeneca GCCAstraZeneca InternationalAbstract Background Eosinophilia is a significant factor in asthma severity; however, the prevalence of severe eosinophilic asthma in Saudi Arabia is largely unknown. We aimed to determine the prevalence of the eosinophilic (defined in this study as ≥ 300 cells/mm3 in blood), atopic (atopic phenotype 1, defined in this study as > 100 IU/mL total serum IgE; atopic phenotype 2, defined in this study as > 150 IU/mL), and overlap phenotypes among patients with severe asthma in Saudi Arabia. Methods A cross-sectional study was conducted in centers specialized in severe asthma management. Patients aged ≥ 12 years with severe asthma were enrolled. Study patients responded to the Global Initiative for Asthma 2018 assessment of asthma control questionnaire and provided study investigators with current information related to the study objectives. Additional medical record data and a blood sample for total serum IgE and complete blood count were collected. Results A total of 101 patients were enrolled; 83% were female and the mean (standard deviation) age was 48.7 (13.2) years. Forty-five (45%) patients had the eosinophilic phenotype, 50 (50%) had atopic phenotype 1, and 25 (25%) had phenotypic overlap (eosinophilic and atopic 1). Forty-one (41%) patients had atopic phenotype 2 and 23 (23%) had phenotypic overlap (eosinophilic and atopic 2). Asthma control and oral corticosteroid use patterns were similar and there were no significant differences in number of asthma exacerbations across phenotypes. Conclusions In Saudi Arabia, 45% of patients with severe asthma had the eosinophilic phenotype, which is most likely an underestimation as no clinical features of eosinophilia were taken into account in the definition of eosinophilia. Approximately half of them had phenotypic overlap with the atopic phenotype. Trial registration NCT03931954; ClinicalTrials.gov, April 30, 2019.https://doi.org/10.1186/s12890-022-01856-9Eosinophilic asthmaAtopic asthmaSaudi ArabiaDisease characteristicsSevere asthma
spellingShingle Hamdan Al-Jahdali
Siraj Wali
Amr S. Albanna
Riyad Allehebi
Hussein Al-Matar
Mohamed Fattouh
Maarten Beekman
Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
BMC Pulmonary Medicine
Eosinophilic asthma
Atopic asthma
Saudi Arabia
Disease characteristics
Severe asthma
title Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
title_full Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
title_fullStr Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
title_full_unstemmed Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
title_short Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study
title_sort prevalence of eosinophilic atopic and overlap phenotypes among patients with severe asthma in saudi arabia a cross sectional study
topic Eosinophilic asthma
Atopic asthma
Saudi Arabia
Disease characteristics
Severe asthma
url https://doi.org/10.1186/s12890-022-01856-9
work_keys_str_mv AT hamdanaljahdali prevalenceofeosinophilicatopicandoverlapphenotypesamongpatientswithsevereasthmainsaudiarabiaacrosssectionalstudy
AT sirajwali prevalenceofeosinophilicatopicandoverlapphenotypesamongpatientswithsevereasthmainsaudiarabiaacrosssectionalstudy
AT amrsalbanna prevalenceofeosinophilicatopicandoverlapphenotypesamongpatientswithsevereasthmainsaudiarabiaacrosssectionalstudy
AT riyadallehebi prevalenceofeosinophilicatopicandoverlapphenotypesamongpatientswithsevereasthmainsaudiarabiaacrosssectionalstudy
AT husseinalmatar prevalenceofeosinophilicatopicandoverlapphenotypesamongpatientswithsevereasthmainsaudiarabiaacrosssectionalstudy
AT mohamedfattouh prevalenceofeosinophilicatopicandoverlapphenotypesamongpatientswithsevereasthmainsaudiarabiaacrosssectionalstudy
AT maartenbeekman prevalenceofeosinophilicatopicandoverlapphenotypesamongpatientswithsevereasthmainsaudiarabiaacrosssectionalstudy